Subcellular localization of the dopamine D2 receptor and coexistence with the calcium-binding protein neuronal calcium sensor-1 in the primate prefrontal cortex

Journal of Comparative Neurology

Volumn 488, Issue 4, 2005, Pages 464-475

  Negyessy, Laszlo ^a,b   Goldman Rakic, Patricia S ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Desensitization; Immunohistochemistry; Non synaptic transmission; Schizophrenia; Synapse

Indexed keywords

CALCIUM BINDING PROTEIN; DOPAMINE 2 RECEPTOR; NEUROLEPTIC AGENT; NEURONAL CALCIUM SENSOR 1; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CELL ULTRASTRUCTURE; CELLULAR DISTRIBUTION; ELECTRON MICROSCOPY; IMMUNOGOLD LABELING; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MACROGLIA; NERVE CELL; NONHUMAN; PREFRONTAL CORTEX; PRIMATE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RECEPTOR DOWN REGULATION;

ANIMALS; CALCIUM-BINDING PROTEINS; IMMUNOHISTOCHEMISTRY; MACACA MULATTA; NEURONAL CALCIUM-SENSOR PROTEINS; NEURONS; NEUROPEPTIDES; PREFRONTAL CORTEX; RECEPTORS, DOPAMINE D2; SUBCELLULAR FRACTIONS; SYNAPSES; TISSUE DISTRIBUTION;

EID: 21644487301     PISSN: 00219967     EISSN: None     Source Type: Journal    
DOI: 10.1002/cne.20601     Document Type: Article

References (44)

1. Awenowicz PW, Porter LL. 2002. Local application of dopamine inhibits pyramidal tract neuron activity in the rodent motor cortex. J Neurophysiol 88:3439-3451.
2. Bentivoglio M, Morelli M. 2005. The organization and circuits of mesencephalic dopaminergic neurons and the distribution of dopamine receptors in the brain. In: Handbook of chemical neuroanatomy, vol 21. Amsterdam: Elsevier. p 1-105.
3. Brozoski TJ, Brown RM, Rosvold HE, Goldman PS. 1979. Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. Science 205:929-932.
4. Chen C, Yu L, Zhang P, Jiang J, Zhang Y, Chen X, Wu Q, Wu Q, Zhao S. 2002. Human neuronal calcium sensor-1 shows the highest expression level in cerebral cortex. Neurosci Lett 319:67-70.
5. Cohen JD, Braver TS, Brown JW. 2002. Computational perspectives on dopamine function in prefrontal cortex. Curr Opin Neurobiol 12:223-229.
6. 1 receptors in prefrontal circuits. Proc Natl Acad Sci U S A 98:295-300.
7. Goldman-Rakic PS, Leranth C, Williams SM, Mons N, Geffard M. 1989. Dopamine synaptic complex with pyramidal neurons in primate cerebral cortex. Proc Natl Acad Sci U S A 86:9015-9019.
8. Goldman-Rakic PS, Muly EC 3rd, Williams GV. 2000. D(1) receptors in prefrontal cells and circuits. Brain Res Brain Res Rev 31:295-301.
9. Gulyas AI, Megias M, Emri Z, Freund TF. 1999. Total number and ratio of excitatory and inhibitory synapses converging onto single interneurons of different types in the CA1 area of the rat hippocampus. J Neurosci 19:10082-10097.
10. 2 dopamine receptor. J Neurosci 22:8476-8486.
11. 2-like receptors: an immunocytochemical study of subtype-specific antibodies in rat and human brain. J Comp Neurol 402:353-371.
12. 2 short isoform in dopaminergic pathways. Proc Natl Acad Sci U S A 95:7731-7736.
13. 2-receptor action in prefrontal cortex. Proc Natl Acad Sci U S A 98:1964-1969.
14. 2 receptors internalize in their low-affinity state. Neuroreport 13:1017-1020.
15. Koh PO, Undie AS, Kabbani N, Levenson R, Goldman-Rakic PS, Lidow MS. 2003. Up-regulation of neuronal calcium sensor-1 (NCS-1) in the prefrontal cortex of schizophrenic and bipolar patients. Proc Natl Acad Sci U S A 100:313-317.
16. 2 dopamine receptors in brain with subtype-specific antibodies. Proc Natl Acad Sci U S A 90:8861-8865.
17. 2 and D4 dopamine receptor mRNAs in the primate cerebral cortex vs. neostriatum: effects of chronic treatment with typical and atypical antipsychotic drugs. J Pharmacol Exp Ther 283:939-946.
18. Lidow MS, Wang F, Cao Y, Goldman-Rakic PS. 1998a. Layer V neurons bear the majority of mRNAs encoding the five distinct dopamine receptor subtypes in the primate prefrontal cortex. Synapse 28:10-20.
19. Lidow MS, Williams GV, Goldman-Rakic PS. 1998b. The cerebral cortex: a case for a common site of action of antipsychotics. Trends Pharmacol Sci 19:136-140.
20. Maggio R, Barbier P, Corsini GU. 1995. Apomorphine continuous stimulation in Parkinson's disease: receptor desensitization as a possible mechanism of reduced motor response. J Neural Transm Suppl 45:133-136.
21. Martone ME, Edelmann VM, Ellisman MH, Nef P. 1999. Cellular and subcellular distribution of the calcium-binding protein NCS-1 in the central nervous system of the rat. Cell Tissue Res 295:395-407.
22. McBain CJ, Freund TF, Mody I. 1999. Glutamatergic synapses onto hippocampal interneurons: precision timing without lasting plasticity. Trends Neurosci 22:228-235.
23. Meador-Woodruff JH, Damask SP, Wang J, Haroutunian V, Davis KL, Watson SJ. 1996. Dopamine receptor mRNA expression in human striatum and neocortex. Neuropsychopharmacology 15:17-29.
24. 2 receptor and tyrosine hydroxylase in the rat ventral pallidum. Synapse 43:151-162.
25. Missale C, Nash SR, Robinson SW, Jaber M, Caron MG. 1998. Dopamine receptors: from structure to function. Physiol Rev 78:189-225.
26. Mrzljak L, Bergson C, Pappy M, Huff R, Levenson R, Goldman-Rakic PS. 1996. Localization of dopamine D4 receptors in GABAergic neurons of the primate brain. Nature 381:245-248.
27. 2 receptors and dopamine receptor interacting proteins in the prefrontal cortex. The 3rd Forum of European Neuroscience, Paris, Abstract 180.2.
28. Nicola SM, Surmeier J, Malenka RC. 2000. Dopaminergic modulation of neuronal excitability in the striatum and nucleus accumbens. Annu Rev Neurosci 23:185-215.
29. Nimchinsky EA, Sabatini BL, Svoboda K. 2002. Structure and function of dendritic spines. Annu Rev Physiol 64:313-353.
30. Paspalas CD, Goldman-Rakic PS. 2004. Microdomains for dopamine volume neurotransmission in primate prefrontal cortex. J Neurosci 24: 5292-5300.
31. Seamans JK, Gorelova N, Durstewitz D, Yang CR. 2001. Bidirectional dopamine modulation of GABAergic inhibition in prefrontal cortical pyramidal neurons. J Neurosci 21:3628-3638.
32. Smiley JF, Goldman-Rakic PS. 1993. Heterogeneous targets of dopamine synapses in monkey prefrontal cortex demonstrated by serial section electron microscopy: a laminar analysis using the silver-enhanced diaminobenzidine sulfide (SEDS) immunolabeling technique. Cereb Cortex 3:223-238.
33. Somogyi P, Tamas G, Lujan R, Buhl EH. 1998. Salient features of synaptic organisation in the cerebral cortex. Brain Res Brain Res Rev 26:113-135.
34. Strange PG. 2001. Antipsychotic drugs: importance of dopamine receptors for mechanisms of therapeutic actions and side effects. Pharmacol Rev 53:119-133.
35. Thierry AM, Glowinski J, Goldman-Rakic PS, Christen J. 1994. Motor and cognitive functions of the prefrontal cortex. Berlin: Springer Verlag.
36. Tseng KY, O'Donnell P. 2004. Dopamine-glutamate interactions controlling prefrontal cortical pyramidal cell excitability involve multiple signaling mechanisms. J Neurosci 24:5131-5139.
37. Tsujimoto T, Jeromin A, Saitoh N, Roder JC, Takahashi T. 2002. Neuronal calcium sensor 1 and activity-dependent facilitation of P/Q-type calcium currents at presynaptic nerve terminals. Science 295:2276-2279.
38. Urban NN, Gonzalez-Burgos G, Henze DA, Lewis DA, Barrionuevo G. 2002. Selective reduction by dopamine of excitatory synaptic inputs to pyramidal neurons in primate prefrontal cortex. J Physiol 539:707-712.
39. Vallone D, Picetti R, Borrelli E. 2000. Structure and function of dopamine receptors. Neurosci Biobehav Rev 24:125-132.
40. Vizi ES, Labos E. 1991 Non-synaptic interactions at presynaptic level. Prog Neurobiol. 37:145-163.
41. 2 receptors are present in prefrontal cortical afferents and their targets in patches of the rat caudate-putamen nucleus. J Comp Neurol 442:392-404.
42. 1 receptors in prefrontal cortex. Nature 376:572-575.
43. 2 dopamine receptors in the basal ganglia of the rat: light and electron microscopy. Neuroscience 65:709-730.
44. Zheng P, Zhang XX, Bunney BS, Shi WX. 1999. Opposite modulation of cortical N-methyl-D-aspartate receptor-mediated responses by low and high concentrations of dopamine. Neuroscience 91:527-535.